Shyam Acharya took the name of another man in India, Sarang Chitale, before he began a new life in Australia, where he registered with the Medical Board of New South Wales (NSW) in 2003, the Sydney Morning Herald reported.
He then used the identity of the doctor to gain employment in the NSW public health system. The authorities have been unable to find or contact him saying his current whereabouts are unknown.
Acharya worked for NSW Health as a junior doctor from 2003 to May 2014 at four hospitals in Australia.
In 2013, Acharya worked for international pharmaceutical company, AstraZeneca, before moving to medical research group Novatech in 2016.
The alleged deception was not detected until November 2016, when the Australian Health Practitioner Regulation Agency began investigating him for "falsely holding himself out as a registered medical practitioner".
Australian Federal Police, the Department of Immigration and Border Protection, and Department of Foreign Affairs and Trade have been alerted.
"It is alleged in these proceedings that Acharya appropriated another doctor's name and medical qualifications while living in India and that he used these stolen and other fraudulent documents to gain registration falsely with the Medical Board of NSW," Crawshaw said.
"The matters currently before the court do not deal with how he was able to enter and leave Australia or how he obtained Australian citizenship in the name of the other doctor," she said.
The matter is due to return to court in early April.
If he is convicted, he faces a fine of up to USD 30,000.
NSW Health said Acharya was a junior doctor with limited registration, meaning he was required to work under the supervision of others.
"It is noted that Acharya's involvement was only as one of a number in the clinical team that treated the patient. NSW Health has notified solicitors acting for the patient," Crawshaw said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
